Reduction of Adipogenesis and Lipid Accumulation by Taraxacum officinale (Dandelion) Extracts in 3T3L1 Adipocytes: An in vitro Study

In this in vitro study, we have investigated the ability of Taraxacum officinale (dandelion) to inhibit adipocyte differentiation and lipogenesis in 3T3‐L1 preadipocytes. HPLC analysis of the three plant extracts used in this study—leaf and root extracts and a commercial root powder—identified caffe...

Full description

Saved in:
Bibliographic Details
Published in:Phytotherapy research Vol. 28; no. 5; pp. 745 - 752
Main Authors: González‐Castejón, Marta, García‐Carrasco, Belén, Fernández‐Dacosta, Raquel, Dávalos, Alberto, Rodriguez‐Casado, Arantxa
Format: Journal Article
Language:English
Published: England J. Wiley 01-05-2014
Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this in vitro study, we have investigated the ability of Taraxacum officinale (dandelion) to inhibit adipocyte differentiation and lipogenesis in 3T3‐L1 preadipocytes. HPLC analysis of the three plant extracts used in this study—leaf and root extracts and a commercial root powder—identified caffeic and chlorogenic acids as the main phenolic constituents. Oil Red O staining and triglyceride levels analysis showed decreased lipid and triglyceride accumulation, respectively. Cytotoxicity was assessed with the MTT assay showing non‐toxic effect among the concentrations tested. DNA microarray analysis showed that the extracts regulated the expression of a number of genes and long non‐coding RNAs that play a major role in the control of adipogenesis. Taken together, our results indicate that the dandelion extracts used in this study may play a significant role during adipogenesis and lipid metabolism, and thus, supporting their therapeutic interest as potential candidates for the treatment of obesity. Copyright © 2013 John Wiley & Sons, Ltd.
Bibliography:http://dx.doi.org/10.1002/ptr.5059
Regional Government of Madrid - No. CPI/0631/2008
Fondo de Investigación Sanitaria - No. FIS, PI11/00315
ark:/67375/WNG-2PZLC6TX-Z
istex:17305C7E798564A7B417F31BD6D51496713C1A83
Supporting info item
Spanish Ministry of Economy and Competitiveness - No. R&C2007-01920
ArticleID:PTR5059
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.5059